Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients With Brain Tumors Under Perillyl Alcohol-Based Therapy
International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms19061610
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 30, 2018
Authors
Publisher
MDPI AG